Overview

Statins and CPAP in Adipose Tissue of OSA

Status:
Enrolling by invitation

Trial end date:
2023-07-01

Target enrollment:

Participant gender:

Summary

This study is aimed at examining the alterations in adipose tissue in obstructive sleep apnea (OSA) patients in response to treatment with atorvastatin in continuation with standard treatment with continuous positive airway pressure (CPAP).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Mayo Clinic

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Atorvastatin
Atorvastatin Calcium